RepliCel Life Sciences Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
| Owner Type | Number of Shares | Ownership Percentage |
|---|---|---|
| Private Companies | 9,344,584 | 14.4% |
| General Public | 23,063,905 | 35.5% |
| Individual Insiders | 32,593,071 | 50.1% |
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Top Shareholders
| Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
|---|---|---|---|---|---|---|
| 17,401,616 | US$745.4k | 0% | no data | |||
| 10,034,537 | US$429.8k | 0% | no data | |||
| 5,357,900 | US$229.5k | 0% | no data | |||
| 3,986,684 | US$170.8k | 0% | no data | |||
| 1,329,245 | US$56.9k | 0% | no data | |||
| 1,193,426 | US$51.1k | 0% | no data | |||
| 875,632 | US$37.5k | 0% | no data | |||
| 626,920 | US$26.9k | 0% | no data | |||
| 489,572 | US$21.0k | 0% | no data | |||
| 320,500 | US$13.7k | 0% | no data | |||
| 314,815 | US$13.5k | 0% | no data | |||
| 6,808 | US$291.5 | 0% | no data |